Associated Papers
Genotype-phenotype analyses of Iranian patients with hemophilia B (Leyden -) and hemophilia B (Leyden +): A single-center study.
Moghadam AA et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis, 2024
Frequency of KRAS and BRAF mutations in colorectal carcinoma and their association with clinical-pathological characteristics in a tertiary hospital in Kenya.
Gakinya S et al.
Frontiers in Medicine, 2024
Evaluation of SNaPshot and Sanger sequencing for the detection of KRAS and NRAS mutations in a sample of Venezuelan patients with colorectal cancer.
Rodríguez-Carrascal D et al.
Ecancermedicalscience, 2024
Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism.
Yang X et al.
Cell Metabolism, 2023
Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins.
Jeong S et al.
Molecular Therapy. Nucleic Acids, 2023
The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.
Hu H et al.
Cell Reports, 2023
Peptides That Block RAS-p21 Protein-Induced Cell Transformation.
Pincus MR et al.
Biomedicines, 2023
The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
Raj N et al.
Molecular Cell, 2022
Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors.
Min BJ et al.
Cancers, 2021
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett KT et al.
Molecular Cell, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
McGrail DJ et al.
Cancer Cell, 2020
Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.
D'Afonseca V et al.
Cancer Informatics, 2020
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
Schmidt L et al.
Leukemia, 2019
Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.
Tirosh I et al.
The Journal of Allergy and Clinical Immunology, 2019
A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence.
Lu B et al.
Cancer Cell, 2018
Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1.
Nimmakayala RK et al.
Gastroenterology, 2018
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Kato S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
Differential roles of STAT3 in the initiation and growth of lung cancer.
Zhou J et al.
Oncogene, 2015
GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W et al.
Virchows Archiv : an International Journal of Pathology, 2015
Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.
Koh M et al.
International Journal of Cancer, 2015
Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.
Tamura K et al.
Surgery, 2015
GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R et al.
Human Pathology, 2014
GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
Sasaki M et al.
Plos One, 2013
Dominant role of the 5' TAR bulge in dimerization of HIV-1 genomic RNA, but no evidence of TAR-TAR kissing during in vivo virus assembly.
Jalalirad M et al.
Biochemistry, 2012
Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.
Brennen WN et al.
Molecular Cancer Therapeutics, 2012
Wnt and Kras signaling-dark siblings in lung cancer.
Pacheco-Pinedo EC et al.
Oncotarget, 2011